Beyond activated partial thromboplastin time: viscoelastic monitoring of argatroban in the critically ill.

Argatroban is increasingly used in critically ill patients, either for heparin-induced thrombocytopenia or as an alternative anticoagulant during extracorporeal support, yet its monitoring remains challenging. Schiferer and colleagues report that the…

Preview only. Read the full abstract at the source